Castle Biosciences Inc
NASDAQ:CSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Castle Biosciences Inc (CSTL) under the Base Case is USD per share.
Compared with the current market price of 33.79 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Castle Biosciences Does
Castle Biosciences makes laboratory tests that help doctors make treatment decisions for cancers and other skin-related conditions. Its best-known products are molecular diagnostic tests, including tests for melanoma and other skin cancers, that analyze tissue samples and give doctors more information about how aggressive a disease may be and how a patient may respond to treatment.
- Headquarters
- United States of America US
- Employees
- 883
- IPO date
- Jul 25, 2019
Revenue & Expenses Breakdown
Castle Biosciences Inc
Earnings Waterfall
Castle Biosciences Inc
Continue CSTL Research
Decided on Castle Biosciences? Get an email when CSTL reaches the price you’d buy at. Free with an account.
Other Castle Biosciences listings
What is the Intrinsic Value of one CSTL stock?
The intrinsic value for
Castle Biosciences Inc (CSTL) under the Base Case is USD.
Is CSTL stock undervalued or overvalued?
Compared with the current market price of 33.79 USD, the stock appears .